ScanSource Reaffirms Its FY25 Guidance: Sees Net Sales Of $3.1B–$3.5B Vs. $3.439B Est.; Adjusted EBITDA Of $140M–$160M, And Free Cash Flow Of At Least $70M

Benzinga
01-30

Annual Financial Outlook for Fiscal Year 2025

ScanSource reaffirms previously provided guidance set forth below for the full fiscal year ended June 30, 2025.

  FY25 Annual Outlook 
Net sales $3.1 billion to $3.5 billion 
Adjusted EBITDA (non-GAAP) $140 million to $160 million 
Free cash flow (non-GAAP) At least $70 million 

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10